131 related articles for article (PubMed ID: 37119922)
1. Bioactive lipid mediators in plasma are predictors of preeclampsia irrespective of aspirin therapy.
Stephenson DJ; MacKnight HP; Hoeferlin LA; Washington SL; Sawyers C; Archer KJ; Strauss JF; Walsh SW; Chalfant CE
J Lipid Res; 2023 Jun; 64(6):100377. PubMed ID: 37119922
[TBL] [Abstract][Full Text] [Related]
2. Plasma cross-gestational sphingolipidomic analyses reveal potential first trimester biomarkers of preeclampsia.
Dobierzewska A; Soman S; Illanes SE; Morris AJ
PLoS One; 2017; 12(4):e0175118. PubMed ID: 28384202
[TBL] [Abstract][Full Text] [Related]
3. Placental Production of Eicosanoids and Sphingolipids in Women Who Developed Preeclampsia on Low-Dose Aspirin.
Walsh SW; Reep DT; Alam SMK; Washington SL; Al Dulaimi M; Lee SM; Springel EH; Strauss JF; Stephenson DJ; Chalfant CE
Reprod Sci; 2020 Dec; 27(12):2158-2169. PubMed ID: 32557282
[TBL] [Abstract][Full Text] [Related]
4. ASPRE trial: risk factors for development of preterm pre-eclampsia despite aspirin prophylaxis.
Shen L; Martinez-Portilla RJ; Rolnik DL; Poon LC
Ultrasound Obstet Gynecol; 2021 Oct; 58(4):546-552. PubMed ID: 33998099
[TBL] [Abstract][Full Text] [Related]
5. Disruption of sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia.
Melland-Smith M; Ermini L; Chauvin S; Craig-Barnes H; Tagliaferro A; Todros T; Post M; Caniggia I
Autophagy; 2015 Apr; 11(4):653-69. PubMed ID: 25853898
[TBL] [Abstract][Full Text] [Related]
6. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
[TBL] [Abstract][Full Text] [Related]
7. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA
J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241
[TBL] [Abstract][Full Text] [Related]
8. Metabolomic biomarkers in midtrimester maternal plasma can accurately predict the development of preeclampsia.
Lee SM; Kang Y; Lee EM; Jung YM; Hong S; Park SJ; Park CW; Norwitz ER; Lee DY; Park JS
Sci Rep; 2020 Sep; 10(1):16142. PubMed ID: 32999354
[TBL] [Abstract][Full Text] [Related]
9. ASPRE trial: performance of screening for preterm pre-eclampsia.
Rolnik DL; Wright D; Poon LCY; Syngelaki A; O'Gorman N; de Paco Matallana C; Akolekar R; Cicero S; Janga D; Singh M; Molina FS; Persico N; Jani JC; Plasencia W; Papaioannou G; Tenenbaum-Gavish K; Nicolaides KH
Ultrasound Obstet Gynecol; 2017 Oct; 50(4):492-495. PubMed ID: 28741785
[TBL] [Abstract][Full Text] [Related]
10. Machine-learning-based prediction of pre-eclampsia using first-trimester maternal characteristics and biomarkers.
Ansbacher-Feldman Z; Syngelaki A; Meiri H; Cirkin R; Nicolaides KH; Louzoun Y
Ultrasound Obstet Gynecol; 2022 Dec; 60(6):739-745. PubMed ID: 36454636
[TBL] [Abstract][Full Text] [Related]
11. Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE.
Tan MY; Poon LC; Rolnik DL; Syngelaki A; de Paco Matallana C; Akolekar R; Cicero S; Janga D; Singh M; Molina FS; Persico N; Jani JC; Plasencia W; Greco E; Papaioannou G; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2018 Jul; 52(1):52-59. PubMed ID: 29704277
[TBL] [Abstract][Full Text] [Related]
12. Routine first-trimester pre-eclampsia screening and risk of preterm birth.
Giorgione V; Quintero Mendez O; Pinas A; Ansley W; Thilaganathan B
Ultrasound Obstet Gynecol; 2022 Aug; 60(2):185-191. PubMed ID: 35441764
[TBL] [Abstract][Full Text] [Related]
13. Prediction and associations of preterm birth and its subtypes with eicosanoid enzymatic pathways and inflammatory markers.
Aung MT; Yu Y; Ferguson KK; Cantonwine DE; Zeng L; McElrath TF; Pennathur S; Mukherjee B; Meeker JD
Sci Rep; 2019 Nov; 9(1):17049. PubMed ID: 31745121
[TBL] [Abstract][Full Text] [Related]
14. Modified multiple marker aneuploidy screening as a primary screening test for preeclampsia.
Huang T; Bedford HM; Rashid S; Rasasakaram E; Priston M; Mak-Tam E; Gibbons C; Meschino WS; Cuckle H; Mei-Dan E
BMC Pregnancy Childbirth; 2022 Mar; 22(1):190. PubMed ID: 35260099
[TBL] [Abstract][Full Text] [Related]
15. Serum PlGF compared with PAPP-A in first trimester screening for preterm pre-eclampsia: Adjusting for the effect of aspirin treatment.
Wright D; Tan MY; O'Gorman N; Syngelaki A; Nicolaides KH
BJOG; 2022 Jul; 129(8):1308-1317. PubMed ID: 35015330
[TBL] [Abstract][Full Text] [Related]
16. Sphingolipids as a new factor in the pathomechanism of preeclampsia - Mass spectrometry analysis.
Charkiewicz K; Goscik J; Blachnio-Zabielska A; Raba G; Sakowicz A; Kalinka J; Chabowski A; Laudanski P
PLoS One; 2017; 12(5):e0177601. PubMed ID: 28542236
[TBL] [Abstract][Full Text] [Related]
17. Quantitative profiling of inflammatory and pro-resolving lipid mediators in human adolescents and mouse plasma using UHPLC-MS/MS.
Hartling I; Cremonesi A; Osuna E; Lou PH; Lucchinetti E; Zaugg M; Hersberger M
Clin Chem Lab Med; 2021 Oct; 59(11):1811-1823. PubMed ID: 34243224
[TBL] [Abstract][Full Text] [Related]
18. Plasma S1P and Sphingosine are not Different Prior to Pre-Eclampsia in Women at High Risk of Developing the Disease.
Johnstone ED; Westwood M; Dilworth M; Wray JR; Kendall AC; Nicolaou A; Myers JE
J Lipid Res; 2023 Jan; 64(1):100312. PubMed ID: 36370808
[TBL] [Abstract][Full Text] [Related]
19. Molecular Targets of Aspirin and Prevention of Preeclampsia and Their Potential Association with Circulating Extracellular Vesicles during Pregnancy.
Dutta S; Kumar S; Hyett J; Salomon C
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31492014
[TBL] [Abstract][Full Text] [Related]
20. Study protocol for the randomised controlled trial: combined multimarker screening and randomised patient treatment with ASpirin for evidence-based PREeclampsia prevention (ASPRE).
O'Gorman N; Wright D; Rolnik DL; Nicolaides KH; Poon LC
BMJ Open; 2016 Jun; 6(6):e011801. PubMed ID: 27354081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
